GROVE CITY MEDICAL CENTER — History
CCN 390266 | 3-year financial timeline | COVID resilience: 82/100
🛡️ Public data only — no PHI permitted on this instance.
$57M
Latest Revenue (FY2022)
+16.8%
Revenue CAGR (3yr)
1.8%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $42M | $50M | $57M | +14.3% | +16.8% |
| Operating Expenses | $45M | $52M | $56M | +7.3% | +11.6% |
| Operating Margin | -7.6% | -4.6% | 1.8% | +139.3% | +0.0% |
| Net Income | $-3M | $-2M | $1M | +144.9% | +0.0% |
| Licensed Beds | 67 | 67 | 67 | +0.0% | +0.0% |
| Total Patient Days | 3,613 | 3,437 | 2,250 | -34.5% | -21.1% |
| Medicare Day % | 29% | 29% | 29% | +1.8% | +0.2% |
| Medicaid Day % | 1% | 1% | 0% | -96.4% | -72.3% |
COVID Impact & Recovery
Resilience Score: 82/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +36.4% ($42M → $57M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+16.8%
This Hospital
+7.6%
State Avg
Latest Margin
1.8%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $65M | 6.5% |
| FY2024 (proj) | $72M | 11.2% |
| FY2025 (proj) | $80M | 15.8% |